...
首页> 外文期刊>Drugs and aging >Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study
【24h】

Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study

机译:患有轻度认知障碍,痴呆和多重慢性病的老年人患者抗胆碱能负荷和秋季或坠落或坠落损伤风险:回顾性队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

BackgroundIt is not known whether drugs with different anticholinergic ratings contribute proportionately to overall anticholinergic score.ObjectivesOur objective was to assess the risk of falls or fall-related injuries as a function of the overall anticholinergic score resulting from drugs with different anticholinergic ratings among people with impaired cognition.MethodsThis was a retrospective cohort study of adults aged 65years with mild cognitive impairment (MCI) or dementia and two or more additional chronic conditions (N=10,698) in an integrated delivery system. Electronic health record data, including pharmacy fills and diagnosis claims, were used to assess anticholinergic medication use, quantified using the anticholinergic cognitive burden (ACB) scale, falls and fall-related injuries.ResultsDuring a median follow-up of 366days, 63% of the cohort used one or more ACB drug; 2015 (18.8%) people experienced a fall or fall-related injury. Among patients with a daily ACB score of 5, the greatest increase in risk of falls or fall-related injuries was seen when level 2 and level 3 drugs were used in combination [hazard ratio (HR) 2.06; 95% confidence interval (CI) 1.51-2.83]. Multiple ACB level 1 drugs taken together alsoincreased the hazard of a fall or fall-related injury (HR 1.16; 95% CI 1.03-1.32). The risk of fall or fall-related injury as a function of exposure to ACB level 2 drugs (HR 1.56; 95% CI 1.16-2.10) was higher than that for ACB level 1 or 3 drugs.ConclusionsThe same daily ACB score was associated with a different degree of risk, depending on the ACB ratings of the individual drugs comprising the score. Combinations of level 2 and level 3 drugs had the greatest risk of fall or fall-related injury relative to other individuals with the same daily ACB score. Low-potency anticholinergic drugs taken together modestlyincreased the hazard of a fall or fall-related injury.
机译:背景技术不知道具有不同抗胆碱能力的药物是否与总体抗胆碱能成绩分为比例。目的是评估患有秋季或患有患有血症损伤的风险,这是由不同抗胆碱能力障碍的药物患有不同的抗胆碱能力的整体抗胆碱能评分的函数认知.Thodsthis是一种回顾性队列研究,成年人65岁的成人,在综合交付系统中具有轻度认知障碍(MCI)或痴呆或痴呆和两种或更多种额外的慢性条件(n = 10,698)。电子健康记录数据包括药房填充和诊断索赔,用于评估抗胆碱能药物使用,使用抗胆碱能认知负担(ACB)规模定量,下降和患有患有患有伤害的损伤。持续366天的中位随访,63%队列使用了一种或多种ACB药物; 2015年(18.8%)人民经历了秋季或坠落坠落造成的伤害。在每日ACB评分5的患者中,当2级和3级药物组合使用[危险比(HR)2.06; 95%置信区间(CI)1.51-2.83]。多种ACB级别1种药物,也可以增加秋季或坠落相关损伤的危害(HR 1.16; 95%CI 1.03-1.32)。与ACB级别2药物暴露的函数下降或坠落或坠落损伤的风险(HR 1.56; 95%CI 1.16-2.10)高于ACB 1或3种药物的功能。相同的每日ACB评分与之相关根据包含分数的个体药物的ACB评级,不同程度的风险。 2级和3级药物的组合具有相对于其他个人ACB得分的其他个体具有最大的堕落或坠毁患者的风险。低效力抗胆碱能药物均匀地采用秋季或坠落或坠落损伤的危害。

著录项

  • 来源
    《Drugs and aging》 |2019年第3期|共9页
  • 作者单位

    Johns Hopkins Univ Sch Med Div Geriatr Med &

    Gerontol Mason F Lord Ctr Tower 7th Floor 5200;

    Kaiser Permanente Colorado Inst Hlth Res Denver CO USA;

    Kaiser Permanente Colorado Inst Hlth Res Denver CO USA;

    Kaiser Permanente Colorado Inst Hlth Res Denver CO USA;

    Johns Hopkins Univ Sch Med Div Geriatr Med &

    Gerontol Mason F Lord Ctr Tower 7th Floor 5200;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 药学;
  • 关键词

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号